Arrayit(OTC) ARYC

Arrayit Corporation is a global life sciences technology firm based in Sunnyvale, California. The company specializes in developing and commercializing advanced tools for genetic analysis, biological functions, and diagnostic applications.

Products and Services

• Microarray instruments and components for genetic analysis
• Custom microarray printing and analysis services
• Diagnostic microarrays for early health condition identification

Growth Outlook

• Innovative microarray technology supports diverse research applications
• Expanding client base includes pharmaceutical and biotechnology firms
• Potential for increased demand in genetic testing and diagnostics

Financial Highlights

• Recent quarterly revenue of 615,151, showing growth potential
• Gross profit margin of 60.32% indicates strong product demand
• Operating cash flow trends suggest ongoing operational challenges

Arrayit Corporation operates in the medical diagnostics and research industry, focusing on innovative solutions for genetic analysis. The company’s product offerings include a range of microarray instruments and custom services, catering to a diverse clientele that spans academic institutions, government agencies, and pharmaceutical companies. The growth outlook appears promising, driven by advancements in microarray technology and an increasing demand for genetic testing. Recent financial data indicates a revenue of 615,151, reflecting the company's ability to generate income despite operational challenges. The gross profit margin of 60.32% highlights the strong demand for its products, although ongoing operational expenses may impact overall profitability. Investors may find Arrayit Corporation an intriguing opportunity within the life sciences sector, particularly as the market for genetic diagnostics continues to expand.